Abstract
Objectives
To assess the volume doubling time (VDT) of lung cancers in IIP compared with COPD.
Methods
A total of 61 patients (32 with IIP and 29 with COPD) were identified. A radiologist performed three-dimensional manual segmentation for lung cancers. VDTs were calculated and compared between two groups. Logistic regression was performed to identify factors associated with rapid tumour growth (VDT < 90 days).
Results
The median VDT of lung cancers in IIP (78.2 days) was significantly shorter than that in COPD (126.1 days; p=0.004). Squamous cell carcinoma (SqCC) was the most frequent subtype, followed by small cell lung cancer (SCLC) in IIP. In COPD, SqCC was the most frequent subtype, followed by adenocarcinoma. Rapid tumour growth was observed in 20 cancers from IIP, and in nine cancers from COPD (p=0.021). SCLC was significantly correlated with rapid tumour growth (p=0.038). Multivariate analysis revealed that the presence of IIP was the single independent predictor of rapid tumour growth (p = 0.016; odds ratio, 3.7).
Conclusions
Lung cancers in IIP showed more rapid growth, with median VDT < 90 days. Therefore, a shorter follow-up interval (<90 days) may be necessary when CT surveillance is considered in IIP patients with suspected lung cancer.
Key Points
• The median VDTs of lung cancers in IIP was 78.2 days.
• Rapid tumour growth occurred more frequently in IIP than in COPD.
• IIP was the single independent predictor of rapid tumour growth.
• Shorter CT follow-up interval may be necessary in IIP with suspicious nodules.
Similar content being viewed by others
Abbreviations
- COPD:
-
Chronic obstructive pulmonary disease;
- CT:
-
Computed tomography;
- FEV1:
-
Forced expiratory volume in 1 s;
- FVC:
-
Forced volume vital capacity;
- IIP:
-
Idiopathic interstitial pneumonia;
- SCLC:
-
Small cell lung cancer;
- SqCC:
-
Squamous cell carcinoma;
- VDT:
-
Volume doubling time
References
Archontogeorgis K, Steiropoulos P, Tzouvelekis A, Nena E, Bouros D (2012) Lung cancer and interstitial lung diseases: a systematic review. Pulm Med 2012:315918
Raghu G, Chen SY, Hou Q, Yeh WS, Collard HR (2016) Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old. Eur Respir J 48:179–186
Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, Hubbard R (2007) The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 101:2534–2540
Raghu G, Nyberg F, Morgan G (2004) The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer 91:S3–10
Nishino M, Cardarella S, Dahlberg SE et al (2015) Interstitial lung abnormalities in treatment-naive advanced non-small-cell lung cancer patients are associated with shorter survival. Eur J Radiol 84:998–1004
Yoshida R, Arakawa H, Kaji Y (2012) Lung cancer in chronic interstitial pneumonia: early manifestation from serial CT observations. AJR Am J Roentgenol 199:85–90
SY O, Kim MY, Kim JE et al (2015) Evolving Early Lung Cancers Detected During Follow-Up of Idiopathic Interstitial Pneumonia: Serial CT Features. AJR Am J Roentgenol 204:1190–1196
Zhao YR, Heuvelmans MA, Dorrius MD et al (2014) Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: the NELSON study. Radiology 270:872–879
MacMahon H, Austin JH, Gamsu G et al (2005) Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 237:395–400
Hasegawa M, Sone S, Takashima S et al (2000) Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 73:1252–1259
Jennings SG, Winer-Muram HT, Tarver RD, Farber MO (2004) Lung tumor growth: assessment with CT--comparison of diameter and cross-sectional area with volume measurements. Radiology 231:866–871
Horeweg N, Scholten ET, de Jong PA et al (2014) Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 15:1342–1350
Wilson DO, Weissfeld JL, Balkan A et al (2008) Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 178:738–744
Schwartz AG, Lusk CM, Wenzlaff AS et al (2016) Risk of lung cancer associated with COPD phenotype based on quantitative image analysis. Cancer Epidemiol Biomark Prev. https://doi.org/10.1158/1055-9965.EPI-16-0176
Bechtel JJ, Kelley WA, Coons TA, Klein MG, Slagel DD, Petty TL (2005) Lung cancer detection in patients with airflow obstruction identified in a primary care outpatient practice. Chest 127:1140–1145
Wells AU (2013) The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)--practical implications. Respir Res 14:S2
Oxnard GR, Zhao B, Sima CS et al (2011) Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes. J Clin Oncol 29:3114–3119
Choe J, Lee SM, Lim S et al (2017) Doubling time of thymic epithelial tumours on CT: correlation with histological subtype. Eur Radiol. https://doi.org/10.1007/s00330-017-4795-y
Schwartz M (1961) A biomathematical approach to clinical tumor growth. Cancer 14:1272–1294
Heuvelmans MA, Oudkerk M, de Bock GH et al (2013) Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 23:1836–1845
Aubry MC, Myers JL, Douglas WW et al (2002) Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin Proc 77:763–770
Park J, Kim DS, Shim TS et al (2001) Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 17:1216–1219
Nagai A, Chiyotani A, Nakadate T, Konno K (1992) Lung cancer in patients with idiopathic pulmonary fibrosis. Tohoku J Exp Med 167:231–237
Govindan R, Page N, Morgensztern D et al (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24:4539–4544
Riaz SP, Luchtenborg M, Coupland VH, Spicer J, Peake MD, Moller H (2012) Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer 75:280–284
Shin A, Oh CM, Kim BW, Woo H, Won YJ, Lee JS (2016) Lung Cancer Epidemiology in Korea. Cancer Res Treat. https://doi.org/10.4143/crt.2016.178
Cheng TY, Cramb SM, Baade PD, Youlden DR, Nwogu C, Reid ME (2016) The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics. J Thorac Oncol 11:1653–1671
Henschke CI, Yankelevitz DF, Yip R et al (2012) Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology 263:578–583
Park JY, Jang SH (2016) Epidemiology of Lung Cancer in Korea: Recent Trends. Tuberc Respir Dis (Seoul) 79:58–69
Mackintosh JA, Marshall HM, Yang IA, Bowman RV, Fong KM (2014) A retrospective study of volume doubling time in surgically resected non-small cell lung cancer. Respirology 19:755–762
Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345:517–525
Schetter AJ, Heegaard NH, Harris CC (2010) Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31:37–49
King TE, Jr. (2011) Smoking and subclinical interstitial lung disease. N Engl J Med 364:968-970
Attili AK, Kazerooni EA, Gross BH, Flaherty KR, Myers JL, Martinez FJ (2008) Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics 28:1383–1396 discussion 1396-1388
Funding
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (grant number: NRF-2016R1A2B1016355).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Sang Min Lee.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Study subjects or cohorts overlap
Of 32 patients with IIP, five were identical to the study population in the previous report (Oh et al. [reference 11]). Oh et al.’s study dealt with CT features of lung cancers detected during follow up of idiopathic interstitial pneumonia, whereas this work addressed VDTs of lung cancer in IIP and compared with VDTs of lung cancer in COPD patients. Thus, this work is substantially different from previous reports.
Methodology
• retrospective
• case-control study
• performed at one institution
Rights and permissions
About this article
Cite this article
Kim, C., Lee, S.M., Choe, J. et al. Volume doubling time of lung cancer detected in idiopathic interstitial pneumonia: comparison with that in chronic obstructive pulmonary disease. Eur Radiol 28, 1402–1409 (2018). https://doi.org/10.1007/s00330-017-5091-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-017-5091-6